Norwalk, CT, November 08, 2017 --(PR.com
)-- HealthPrize Technologies, a provider of adherence and patient engagement technology for the life sciences industry, announced today the appointment of Michael Griffith to its Board of Directors. Griffith is an operating partner of San Francisco-based private equity firm Altamont Capital Partners.
“We are excited to bring Michael onto our Board and look forward to benefiting from the insights he will bring to the company,” said Tom Kottler, Co-founder and CEO of HealthPrize. “Michael’s decades of experience selling services and products into the pharmaceutical industry will be of utmost value as we continue to grow and expand our reach in the marketplace.”
Griffith holds 20 years of executive-level expertise in pharmaceutical services. Prior to Altamont, he was the President of the Commercial Division of inVentiv Health, a provider of outsourced services to pharma; CEO at Laureate Biopharma, a contract development and manufacturing company that specializes in protein therapeutics; Founder and CEO of Aptuit, a contract drug development company; and Chairman and CEO of ChiRex, a contract drug development and manufacturing company.
“HealthPrize’s novel approach to the challenges of engaging and motivating patients has shown consistent, verified effectiveness,” said Griffith. “I look forward to helping guide the company to strengthen its position as an industry-standard platform for medication adherence and pharmaceutical brand differentiation.”
Life science companies worldwide use HealthPrize’s technology to develop digital patient experiences that improve adherence, increase health literacy, and provide brand differentiation. The company’s gamification- and behavioral economics-based platform powers and advances patient engagement for branded and generic medications across all therapeutic areas, demographics and drug delivery methods.
About HealthPrize Technologies: HealthPrize Technologies enables life science companies to engage and motivate their customers using gamification, education, behavioral economics and incentives. The company's proven approach results in measurable outcomes across all therapeutic areas, demographics and geographies to deliver the greatest prize of all – better health. Learn more at HealthPrize.com or follow @HealthPrize on Twitter.